FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Lotus Eye Hospital & Institute's FCF Yield % or its related term are showing as below:
BOM:532998'
s FCF Yield % Range Over the Past 10 Years
Min: -4.02 Med: 0 Max: 0
Current: -4.02
BOM:532998's FCF Yield % is ranked worse than 70.82% of 682
companies
in the Healthcare Providers & Services industry
Industry Median: 1.835
vs BOM:532998: -4.02
Lotus Eye Hospital & Institute FCF Yield % Explanation
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Lotus Eye Hospital & Institute FCF Yield % Related Terms
Lotus Eye Hospital & Institute FCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:532998 vs HCA, THC, DVA: FCF Yield % Comparison
For the Medical Care Facilities subindustry, Lotus Eye Hospital & Institute's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lotus Eye Hospital & Institute FCF Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Lotus Eye Hospital & Institute's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Lotus Eye Hospital & Institute's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lotus Eye Hospital & Institute (BOM:532998) has a FCF Yield % of -4.02 as of Jul. 09, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Lotus Eye Hospital & Institute and its competitors. According to the industry distribution chart, Lotus Eye Hospital & Institute ranks #483 out of 682 companies in the Healthcare Providers & Services industry, placing it in the top 70.8%.
Is Lotus Eye Hospital & Institute's FCF Yield % too high?
Lotus Eye Hospital & Institute's current FCF Yield % is -4.02. Based on the distribution chart, Lotus Eye Hospital & Institute ranks #483 out of 682 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Lotus Eye Hospital & Institute has a GF Score™ of 67/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Lotus Eye Hospital & Institute's FCF Yield % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Lotus Eye Hospital & Institute ranks #483 out of 682 companies for FCF Yield %. This places Lotus Eye Hospital & Institute in the lower half of its industry. The industry median FCF Yield % is 1.84. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Healthcare Providers & Services company?
The median FCF Yield % among Healthcare Providers & Services companies is 1.84, based on 682 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Lotus Eye Hospital & Institute and its competitors. For the Healthcare Providers & Services industry, the median FCF Yield % is 1.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lotus Eye Hospital & Institute's current FCF Yield % is -4.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lotus Eye Hospital & Institute stock overvalued right now?
Based on GuruFocus' analysis, Lotus Eye Hospital & Institute (BOM:532998) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹91.98, compared to a current price of ₹119.70 — trading 30.1% above its estimated fair value. The current FCF Yield % is -4.02. Lotus Eye Hospital & Institute's overall GF Score™ is 67/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Lotus Eye Hospital & Institute (BOM:532998), the current FCF Yield % is -4.02 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Lotus Eye Hospital & Institute (BOM:532998) Overvalued in 2026?
Based on GuruFocus' analysis, Lotus Eye Hospital & Institute stock appears to be overvalued.
The current stock price of ₹119.70 is trading 30.1% above its estimated GF Value™ of ₹91.98.
GuruFocus considers Lotus Eye Hospital & Institute to be Modestly Overvalued.
Key valuation signals for BOM:532998:
FCF Yield %: -4.02
GF Value™: ₹91.98 vs. price of ₹119.70 (30.1% above fair value)
No single metric tells the full story. See the BOM:532998 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Lotus Eye Hospital & Institute Business Description
Lotus Eye Hospital & Institute Ltd is an India-based eye care hospital. It is engaged in providing treatment and care for eye diseases and disorders. It offers treatment services for eye conditions like refractive error, retina and uvea, cornea, glaucoma, pediatric, orbit and oculoplasty, neuro-ophthalmology, and binocular vision. In addition, the company also operates an eye bank for functioning eye donation activities. The company mainly operates in India and generates revenue by providing medical services, pharmacy sales, contact lenses, and optical, of which the majority of the revenue is derived from providing segmmedical services.
67GF Score
Get the complete analysis for BOM:532998
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:532998 has been successfully added to your 
